UnitedHealth Group on Tuesday reported third-quarter results that exceeded Wall Street expectations, as the company makes progress in managing high medical costs through a combination of value-based care investments and AI initiatives.
The company posted adjusted earnings of $4.69 per share, compared with the $4.14 analysts had expected, according to LSEG. Revenue came in at $112.69 billion versus the $111.40 billion consensus estimate. Net income rose sharply to $4.11 billion, or $4.56 per share, from $2.35 billion, or $2.59 per share, a year earlier.
UnitedHealth raised its full-year adjusted earnings outlook to at least $20.50 per share, up from a previous forecast of $19.50 to $20. Shares rose about 3% in premarket trading.
A key metric watched by investors, the medical cost ratio—total medical expenses paid relative to premiums collected—improved to 88.4% in the quarter, better than the 89.9% analysts had expected. A lower ratio indicates higher profitability.
CFO Wayne DeVeydt said in an interview that the quarter reflected continued execution on financials and a focus on investing heavily in value-based care. However, he cautioned that medical costs "continue to be elevated versus historical norms," noting that the independent dispute resolution process under the No Surprises Act adds at least one percentage point to the medical cost ratio.
DeVeydt said the company's medical care ratio has improved significantly but added that underlying medical cost trends remain something to watch. Both UnitedHealthcare and the Optum healthcare unit topped analysts' operating earnings estimates for the quarter, according to StreetAccount.